Effectiveness of TNFi versus Non-TNFi Biologics on Disease Activity in Obese Patients with Rheumatoid Arthritis: Data from the ACR's RISE Registry

被引：0
|
作者：
Gianfrancesco, Milena [1 ]
Li, Jing [1 ]
Ja, Clairissa [2 ]
Seet, Andrea [1 ]
Schmajuk, Gabriela [1 ]
Yazdany, Jinoos [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA USA
[2] Univ Calif Davis, San Francisco, CA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0588
引用
收藏
页码：1193 / 1194
页数：2
相关论文
共 50 条
  • [1] REAL-WORLD EFFECTIVENESS OF TNFI VERSUS NON-TNFI BIOLOGICS ON DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS: DATA FROM THE ACR'S RISE REGISTRY
    Gianfrancesco, M.
    Li, J.
    Evans, M.
    Petersen, M.
    Schmajuk, G.
    Yazdany, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 65 - 66
  • [2] RISK OF HEART FAILURE FOLLOWING EXPOSURE TO NON-TNFI COMPARED TO TNFI BIOLOGICS IN US PATIENTS WITH RHEUMATOID ARTHRITIS
    Jensen, Thomas Bo
    Tsao, Nicole
    Pawar, Ajinkya
    Desai, Rishi J.
    Kim, Seoyoung
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1392 - 1392
  • [3] Risk of heart failure following exposure to non-TNFi compared to TNFi biologics in US patients with rheumatoid arthritis
    Jensen, Thomas Bo
    Tsao, Nicole
    Pawar, Ajinkya
    Desai, Rishi
    Kim, Seoyoung
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 421 - 421
  • [4] Practice Variation in Prescriptions of Non-TNFi Biologics and Tofacitinib: Data from the Rheumatology Informatics System for Effectiveness (RISE) Registry
    Schmajuk, Gabriela
    Evans, Michael
    Kay, Julia
    Clowse, Megan E. B.
    Morgan, Esi
    Reimold, Andreas
    Johansson, Tracy
    Lewis, Lindsay
    Yazdany, Jinoos
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [5] Switching to TNFi versus non-TNFi biologics in Crohn's Disease patients: Real-world outcomes from a German claims data analysis
    Antolin-Fontes, B.
    Borsi, A.
    Nissinen, R.
    Bravata, I.
    Barthelmes, J. N.
    Le Bars, M.
    Lee, J.
    Maywald, U.
    Bokemeyer, B.
    Wilke, T.
    Ghiani, M.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S189 - S191
  • [6] The Comparative Effectiveness of First-Line Tumor Necrosis Factor Inhibitor (TNFi) Compared with Non-TNFi Agents in Patients with Rheumatoid Arthritis: Results from the Corrona Registry
    Pappas, Dimitrios A.
    St John, Gregory
    Etzel, Carol J.
    Fiore, Stefano
    Blachley, Taylor
    Kimura, Toshio
    Punekar, Rajeshwari
    Emeanuru, Kelechi
    Boklage, Susan
    Kremer, Joel
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [7] SWITCHING TO TNFI VERSUS NON-TNFI BIOLOGICS IN ULCERATIVE COLITIS PATIENTS: REAL-WORLD OUTCOMES FROM A GERMAN CLAIMS DATA ANALYSIS
    Zhuleku, E.
    Wirth, D.
    Nissinen, R.
    Passey, A.
    Bravata, I
    Ziavra, D.
    Duva, A.
    Lee, J.
    Maywald, U.
    Wilke, T.
    Bokemeyer, B.
    VALUE IN HEALTH, 2023, 26 (12) : S525 - S526
  • [8] DISCONTINUATION AND EFFECTIVENESS OF ORIGINATOR AND BIOSIMILAR TNFI IN PATIENTS WITH RHEUMATOID ARTHRITIS: REAL WORLD DATA FROM A RHEUMATOID ARTHRITIS REGISTRY IN CANADA
    Movahedi, M.
    Cesta, A.
    Li, X.
    Bombardier, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1381 - 1381
  • [9] Effectiveness of Monotherapy in Rheumatoid Arthritis (RA) Patients Initiating a Tumor Necrosis Factor Inhibitor (TNFi) Vs a Non-TNFi in a Large US Commercial and Medicare Advantage Plan
    Chastek, Benjamin
    Curtis, Jeffrey R.
    Becker, Laura K.
    Joseph, George J.
    Chen, Chieh-I
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [10] Physician- and Patient-reported Effectiveness Are Similar for Tofacitinib and TNFi in Rheumatoid Arthritis: Data From a Rheumatoid Arthritis Registry
    Movahedi, Mohammad
    Cesta, Angela
    Li, Xiyuing
    Keystone, Edward C.
    Bombardier, Claire
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (05) : 447 - 453
12345